Matthew Hamilton Rosenberg’s AstraZeneca AZN Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$344K	Buy	2,129 +78	+4%	+$13K	0.06%	154
2026 Q2	$389K	Buy	+2,051	New	+$386K	0.07%	131
2026 Q1	–	Sell	-1,607	Closed	-$295K	–	802
2025 Q4	$295K	Hold	1,607	–	–	0.06%	152
2025 Q3	$247K	Sell	1,607 -22	-1%	-$3.33K	0.05%	175
2025 Q2	$228K	Buy	1,629 +1,015	+165%	+$142K	0.05%	185
2025 Q1	$90.3K	Buy	614 +46	+8%	+$6.66K	0.02%	335
2024 Q4	$74.4K	Sell	568 -202	-26%	-$28.3K	0.02%	354
2024 Q3	$120K	Hold	770	–	–	0.03%	282
2024 Q2	$120K	Buy	770 +105	+16%	+$15.8K	0.04%	256
2024 Q1	$89.4K	Sell	665 -49	-7%	-$6.49K	0.03%	333
2023 Q4	$96.2K	Sell	714 -22	-3%	-$2.86K	0.03%	318
2023 Q3	$99.7K	Sell	736 -63	-8%	-$8.61K	0.03%	283
2023 Q2	$114K	Buy	799 +1	+0.1%	+$147	0.04%	266
2023 Q1	$111K	Hold	798	–	–	0.04%	290
2022 Q4	$108K	Hold	798	–	–	0.04%	292
2022 Q3	$88K	Hold	798	–	–	0.03%	313
2022 Q2	$105K	Hold	798	–	–	0.04%	289
2022 Q1	$106K	Hold	798	–	–	0.04%	295
2021 Q4	$93K	Buy	798 +409	+105%	+$48.1K	0.03%	312
2021 Q3	$47K	Buy	389 +98	+34%	+$11.4K	0.02%	399
2021 Q2	$35K	Hold	291	–	–	0.02%	410
2021 Q1	$29K	Hold	291	–	–	0.02%	397
2020 Q4	$29K	Sell	291 -171	-37%	-$18.1K	0.02%	382
2020 Q3	$51K	Hold	462	–	–	0.04%	306
2020 Q2	$49K	Buy	+462	New	+$47.7K	0.04%	310

Other funds holding AZN

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

PNC

Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return

CCM

Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CNBT

Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Matthew Hamilton Rosenberg's AZN Position: Q3 2026 in Review

Matthew Hamilton Rosenberg increased its AstraZeneca (AZN) stake by 3.8% in Q3 2026, buying an estimated $13K and bringing the position to 2,129 shares worth $344K. The position accounts for 0.06% of the portfolio, ranked #154.

Matthew Hamilton Rosenberg first reported a position in AZN in Q2 2020 and has held it in 25 quarters since. The position peaked at $389K in Q2 2026. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Matthew Hamilton Rosenberg held 2,129 shares of AstraZeneca worth $344K as of Q3 2026.
Matthew Hamilton Rosenberg bought 78 AstraZeneca shares in Q3 2026, an estimated $13K.
AstraZeneca made up 0.06% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #154 holding.
Matthew Hamilton Rosenberg first reported a position in AstraZeneca in Q2 2020 and has held it in 25 quarters since.
Matthew Hamilton Rosenberg's AstraZeneca position peaked at $389K in Q2 2026.
47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.